Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes With Novel Approaches to Targeted Therapy

Share

Program Content

Activities

  • R/R DLBCL
    Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 08, 2023

Faculty

cover img faculity

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado